# Anaesthetic Management of a Patient With a Giant Ovarian Tumour Containing 28 Litres of Ascitic Fluid

**Authors:** Rahul Kalshan, Trisha Nidhi

PMC · DOI: 10.7759/cureus.101824 · Cureus · 2026-01-19

## TL;DR

This paper describes the anesthetic care for a patient with a large ovarian tumor and significant fluid buildup.

## Contribution

The paper presents a detailed case report on managing anesthesia for a patient with a 28-liter ascites-containing ovarian tumor.

## Key findings

- The patient's preoperative condition included a 186 cm abdominal circumference and METs less than 3.5.
- Anesthesia challenges included ventilatory management, hemodynamic stability, and postoperative pain control.

## Abstract

We report the anaesthetic management of a 47-year-old woman scheduled for tumour resection of a giant ovarian tumour containing 28 litres of ascitic fluid. Her preoperative abdominal circumference was 186 cm due to massive ascites, and metabolic equivalents (METs) were less than 3.5. She was planned for cytoreductive surgery under general anaesthesia combined with epidural analgesia. Anaesthetic challenges included ventilatory management to maintain airway pressures, haemodynamic stability during massive fluid shifts, extensive monitoring, pre-induction epidural catheter placement, prevention of hypothermia, correction of metabolic or electrolyte derangements, and adequate postoperative pain relief.

## Linked entities

- **Diseases:** ovarian tumour (MONDO:0021068)

## Full-text entities

- **Genes:** ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}
- **Diseases:** hydrothorax (MESH:D006876), hypotensive (MESH:D007022), vomiting (MESH:D014839), Neuromuscular blockade (MESH:D020879), Mallampati grade II (MESH:D001254), abdominal distension (MESH:D000007), obese (MESH:D009765), nausea (MESH:D009325), weight gain (MESH:D015430), lymphadenopathy (MESH:D008206), ventilatory compromise (MESH:D012131), Giant Ovarian Tumour (MESH:D010051), cancer (MESH:D009369), postoperative pain (MESH:D010149), coagulation (MESH:D001778), lower extremity oedema (MESH:C536897), Blood loss (MESH:D016063), pulmonary oedema (MESH:D011654), hypothermia (MESH:D007035), Ascites (MESH:D001201), apnoea (MESH:D001049), mucinous cystadenocarcinoma of the ovary (MESH:D018282), Massive (MESH:D014202), hypothyroidism (MESH:D007037), hypertension (MESH:D006973)
- **Chemicals:** sevoflurane (MESH:D000077149), propofol (MESH:D015742), CO2 (MESH:D002245), H2O (MESH:D014867), bupivacaine (MESH:D002045), nitrous oxide (MESH:D009609), fentanyl (MESH:D005283), lactate (MESH:D019344), adrenaline (MESH:D004837), 18F-FDG (MESH:D019788), lignocaine (MESH:D008012), rocuronium (MESH:D000077123), oxygen (MESH:D010100), potassium (MESH:D011188)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12914496/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12914496/full.md

## References

12 references — full list in the complete paper: https://tomesphere.com/paper/PMC12914496/full.md

---
Source: https://tomesphere.com/paper/PMC12914496